Malaysia’s pharmaceutical industry is valued at more than US$1.2 billion in 2020, comprising of over 100 companies who can be roughly categorized into three categories:
Generic drug manufacturers. Research-based pharmaceutical companies and Over-the-counter (OTC) manufacturers.
Increasing demand for pharmaceuticals is fueled by increasing health literacy, an ageing population, and a rise in non-communicable diseases like diabetes, hypercholesterolemia, hypertension, and other related medical conditions. Local generic manufacturers are only able to supply 30 percent of the domestic demand with the remainder being covered by imports.
According to the Drug Control Authority (DCA) of the Ministry of Health, as of December 2019, there were 263 licensed manufacturers with 69.2 per cent or 182 of these manufacturers categorized into producers of traditional medicine, 26.6 per cent or 70 being producers of pharmaceuticals and 4.2 per cent or 11 companies being producers of veterinary products.
Pharma14 is glad to be adding the medicine and pricing data for Malaysia this month.
Sample data: Herceptin and Xolair. June 2021 data